✦ LIBER ✦

Direct endoscopic jejunosotomy for the administration of levodopa–carbidopa intestinal gel in Parkinson's disease

✍ Scribed by Kimber, Thomas E.; Schoeman, Mark

Book ID: 122110111
Publisher: Elsevier Science
Year: 2014
Tongue: English
Weight: 153 KB
Volume: 20
Category: Article
ISSN: 1353-8020
DOI: 10.1016/j.parkreldis.2014.03.015

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pharmacokinetics of Levodopa, Carbidopa,

Pharmacokinetics of Levodopa, Carbidopa, and 3-O-Methyldopa Following 16-hour Jejunal Infusion of Levodopa-Carbidopa Intestinal Gel in Advanced Parkinson’s Disease Patients

✍ Dag Nyholm, Per Odin, Anders Johansson, Krai Chatamra, Charles Locke… 📂 Article 📅 2012 🏛 American Association of Pharmaceutical Scientists 🌐 English ⚖ 261 KB

Treatment of advanced Parkinson’s diseas

Treatment of advanced Parkinson’s disease with levodopa/carbidopa intestinal gel is associated with improvements in Hoehn and Yahr stage

✍ A. Munro Neville; Richard W. Parsons; Håkan Askmark; Dag Nyholm 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 101 KB

A cost-effectiveness analysis of levodop

A cost-effectiveness analysis of levodopa/carbidopa intestinal gel compared to standard care in late stage Parkinson’s disease in the UK

✍ Lowin, Julia; Bergman, Annika; Ray Chaudhuri, K.; Findley, Leslie J.; Roeder, Cl 📂 Article 📅 2011 🏛 Informa plc 🌐 English ⚖ 259 KB

Continuous intrajejunal infusion of levo

Continuous intrajejunal infusion of levodopa-carbidopa intestinal gel for patients with advanced Parkinson's disease: a randomised, controlled, double-blind, double-dummy study

✍ Olanow, C Warren; Kieburtz, Karl; Odin, Per; Espay, Alberto J; Standaert, David 📂 Article 📅 2014 🏛 The Lancet 🌐 English ⚖ 309 KB

A long-term, open-label study of levodop

A long-term, open-label study of levodopa–/INS;carbidopa intestinal gel in advanced Parkinson's disease patients: safety and motor-symptom endpoints

✍ Espay, A.J.; Odin, P.; Fernandez, H.H.; Hauser, R.A.; Standaert, D.G.; Lang, A.E 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 62 KB

A long-term, open-label study of levodop

A long-term, open-label study of levodopa–/INS;carbidopa intestinal gel in advanced Parkinson's disease patients: Functional and health-related quality-of-life endpoints

✍ Standaert, D.G.; Fernandez, H.H.; Odin, P.; Hauser, R.A.; Espay, A.J.; Steiger, 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 76 KB